The Schott Group is expanding its production capacity for pharmaceutical glass in response to growing global demand.
The company plans to commission a new melting tank for its Type I glass named FIOLAX® clear at its site in Mitterteich, Germany, increasing the company’s production capacity for glass tubing to more than 140,000 tons. Schott will be investing a sum in the mid-double-digit millions in the expansion.
FIOLAX® glass tubing is used to manufacture high-quality vials, syringes, ampoules and cartridges. The pharmaceutical industry then fills these with injectable drugs. The needs of the pharmaceutical companies for such high-quality packaging are rising steadily because of an ever-increasing regulatory pressure and more stringent standards for patient safety. FIOLAX® is designed to meet these exact requirements. Thanks to its special properties and its chemical resistance the drugs are kept stored in the best possible way. Since it was first developed more than 100 years ago, FIOLAX® has grown to become the de-facto standard for glass packaging in the pharmaceutical industry.
Construction work on the new tank has already begun and will be completed in spring 2016. A new palletizing line will complement the extension.